Physician profile
Emily Detsch
NPI 1750801866
$1,552.52
in general payments reported to CMS, 2019-2025
16 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $90.71 · 2020: $101 · 2021: $452 · 2022: $749 · 2023: $160.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $160.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $160.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Johnson & Johnson Vision Care, INC. | $638.65 | 2019-2022 | |
| Glaukos Corporation | $250.69 | 2021-2022 | |
| Alcon Vision LLC | $217.39 | 2019-2023 | Total30, Dailies Total1, Precision 1 |
| Kala Pharmaceuticals, INC. | $79.98 | 2021-2022 | |
| Abbvie INC. | $72.96 | 2022-2023 | Alphagan P, Vuity, Lumigan |
| Novartis Pharmaceuticals Corporation | $54.75 | 2020-2023 | |
| Biotissue Holdings INC. | $46.95 | 2019-2020 | |
| Allergan, INC. | $39.63 | 2021 | |
| Sight Sciences, INC. | $35.17 | 2021-2022 | |
| Aerie Pharmaceuticals, INC. | $20.50 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $20.27 | 2021 | |
| Carl Zeiss Meditec Ag | $19.40 | 2020 | |
| Omeros Corporation | $16.11 | 2021 | |
| Oyster Point Pharma, INC. | $14.74 | 2023 | Tyrvaya |
| Bausch & Lomb Americas INC. | $14.30 | 2023 | Alrex, Vyzulta, Zylet |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coopervision INC. | $11.03 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Emily Detsch listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.